Prognosis of Guillain-Barré syndrome in the African: the Nigerian experience.
The clinical features of the Guillain-Barré syndrome in 34 Nigerian patients are reported. The patients were treated with oral prednisolone 20 mg three times daily for a minimum of six weeks. Twenty-seven patients recovered completely and five others showed considerable improvement, although three of them appeared to be `steroid dependent'. Two patients died. The good prognosis and the response to treatment with prednisolone in this series is in keeping with an allergic demyelinating neuropathy.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D003391:Cranial Nerves; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009549:Nigeria; D011128:Polyradiculopathy / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use*; D011379:Prognosis; D012621:Seasons; D012737:Sex Factors; D012959:Socioeconomic Factors
D002556:Cerebrospinal Fluid Proteins; D011239:Prednisolone